NEXUS SALES PARTNER LIMITED is an innovative enterprise integrating international trade, technology development, technology consulting, and technology transfer. The company focuses on the full industry chain layout in the novel tobacco alternative product sector, providing professional product and technology solutions to global markets.

The company’s core business revolves around novel tobacco alternative products such as nicotine raw materials and oral nicotine pouches, covering three major segments: commissioned technology R&D, technology transfer, and product trading. Leveraging the deep foundation of the biomedical industry cluster in Chongqing, China, the company has pioneered the cross‑application of cutting‑edge technologies from the pharmaceutical field—including compound synthesis, pharmaceutical formulation, and controlled release of active ingredients—into the R&D and manufacturing of novel tobacco alternative products. Through technological integration and innovation, the company has achieved breakthrough results in key areas such as nicotine synthesis and extraction process optimization, flavor formulation, and the development of oral pouch formulations. This has enabled the construction of a product system that combines safety and innovation, offering smokers worldwide a greater range of tobacco alternative choices.